FREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series of Q3 2025 advancements for KetoAir™, including expanded deployment, the launch of a first-responder metabolic health program, and entry into an international market. Key Highlights Launched Holistic Health Reset Program with First Responders in NevadaIn August 2025, Avalon, together with Saga Health and Specialty ...

Core Insights - Avalon GloboCare Corp. has partnered with SpecialtyHealth, Inc. to enhance its BrAce 4 Impact Challenge, integrating SpecialtyHealth into its Zero to Keto Affiliate Marketing Program [1][6] - The KetoAir™ breathalyzer is being utilized by law enforcement as a motivational tool to support health and wellness initiatives [2][3] - The collaboration aims to promote healthier habits among first responders by managing ketone levels through the use of the KetoAir™ device [4][6] Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy [8] - The company is currently marketing the KetoAir™ breathalyzer, which is registered as a Class I medical device with the U.S. Food and Drug Administration [6][8] - Avalon also operates in the commercial real estate sector, indicating a diversified business model [8] Product Details - The KetoAir™ breathalyzer measures breath acetone concentration, providing real-time insights into an individual's ketosis status [6] - The device is designed for ease of use, fitting into a uniform pocket for convenient monitoring by law enforcement officers [3] - The technology behind KetoAir™ leverages nano-sensor capabilities to assess ketone levels, supporting users in their weight management efforts [6]